Literature DB >> 25924174

MRI helps depict clinically undetectable risk factors in advanced stage retinoblastomas.

Paolo Galluzzi1, Theodora Hadjistilianou2, Alfonso Cerase3, Paolo Toti4, Sara Leonini3, Sandra Bracco3, Sonia de Francesco2, Daniela Galimberti5, Donatella Balducci6, Pietro Piu7, Lucia Monti3, Matteo Bellini3, Mauro Caini5, Alessandro Rossi3.   

Abstract

This study compared high-resolution MRI with histology in advanced stage retinoblastomas in which ophthalmoscopy and ultrasonography did not give an exhaustive depiction of the tumour and/or its extension. MRI of orbits and head in 28 retinoblastoma patients (28 eyes) treated with primary enucleation were evaluated. Iris neoangiogenesis, infiltrations of optic nerve, choroid, anterior segment and sclera suspected at MR and histology were compared. Abnormal anterior segment enhancement (AASE) was also correlated with histologically proven infiltrations. Brain images were also evaluated. Significant values were obtained for: prelaminar optic nerve (ON) sensitivity (0.88), positive predictive value (PPV) (0.75) and negative predictive value (NPV) (0.71); post-laminar ON sensitivity (0.50), specificity (0.83), PPV (0.50) and NPV (0.83); overall choroid sensitivity (0.82), and massive choroid NPV (0.69); scleral specificity (1), and NPV (1). AASE correlated with iris neoangiogenesis in 14 out of 19 eyes, and showed significant values for: overall ON PPV (0.65), prelaminar ON sensitivity (0.65), and PPV (0.61), post-laminar ON NPV (0.64); overall choroid sensitivity (0.77), PPV (0.59) and NPV (0.73); scleral NPV (0.83); anterior segment sensitivity (1), and NPV (1). Odds ratios (OR) and accuracy were significant in scleral and prelaminar optic nerve infiltration. Brain examination was unremarkable in all cases. High-resolution MRI may add important findings to clinical evaluation of advanced stage retinoblastomas.
© The Author(s) 2015 Reprints and permissions:]br]sagepub.co.uk/journalsPermissions.nav.

Entities:  

Keywords:  magnetic resonance imaging; retinoblastoma

Mesh:

Year:  2015        PMID: 25924174      PMCID: PMC4757124          DOI: 10.15274/NRJ-2014-10103

Source DB:  PubMed          Journal:  Neuroradiol J        ISSN: 1971-4009


  26 in total

1.  Chemoreduction in the management of retinoblastoma.

Authors:  Jerry A Shields; Carol L Shields; Anna T Meadows
Journal:  Am J Ophthalmol       Date:  2005-09       Impact factor: 5.258

2.  Orbital and ocular imaging using 3- and 1.5-T MR imaging systems.

Authors:  Mahmood F Mafee; Mark Rapoport; Afshin Karimi; Sameer A Ansari; Jay Shah
Journal:  Neuroimaging Clin N Am       Date:  2005-02       Impact factor: 2.264

3.  "C-scan" ultrasound imaging of optic nerve extension of retinoblastoma.

Authors:  P T Finger; J P S Garcia; M J Pro; S Schneider; A Rausen
Journal:  Br J Ophthalmol       Date:  2005-09       Impact factor: 4.638

4.  Eye imaging with a 3.0-T MRI using a surface coil--a study on volunteers and initial patients with uveal melanoma.

Authors:  Arne-Jörn Lemke; Minouche Alai-Omid; Susanne Anja Hengst; Iris Kazi; Roland Felix
Journal:  Eur Radiol       Date:  2006-01-06       Impact factor: 5.315

5.  Relevance of CT and MRI in retinoblastoma for the diagnosis of postlaminar invasion with normal-size optic nerve: a retrospective study of 150 patients with histological comparison.

Authors:  Hervé J Brisse; Myriam Guesmi; Isabelle Aerts; Xavier Sastre-Garau; Alexia Savignoni; Livia Lumbroso-Le Rouic; Laurence Desjardins; François Doz; Bernard Asselain; Danièle Bours; Sylvia Neuenschwander
Journal:  Pediatr Radiol       Date:  2007-05-04

6.  A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results.

Authors:  David H Abramson; Ira J Dunkel; Scott E Brodie; Jonathan W Kim; Y Pierre Gobin
Journal:  Ophthalmology       Date:  2008-03-14       Impact factor: 12.079

7.  Is CT still useful in the study protocol of retinoblastoma?

Authors:  P Galluzzi; T Hadjistilianou; A Cerase; S De Francesco; P Toti; C Venturi
Journal:  AJNR Am J Neuroradiol       Date:  2009-07-17       Impact factor: 3.825

8.  Proceedings of the consensus meetings from the International Retinoblastoma Staging Working Group on the pathology guidelines for the examination of enucleated eyes and evaluation of prognostic risk factors in retinoblastoma.

Authors:  Xavier Sastre; Guillermo L Chantada; François Doz; Matthew W Wilson; Maria T G de Davila; Carlos Rodríguez-Galindo; Murali Chintagumpala; Patricia Chévez-Barrios
Journal:  Arch Pathol Lab Med       Date:  2009-08       Impact factor: 5.534

9.  Survival with retinoblastoma in the USA: 1975-2004.

Authors:  E Broaddus; A Topham; A D Singh
Journal:  Br J Ophthalmol       Date:  2008-08-21       Impact factor: 4.638

10.  Lack of correlation between the histologic and magnetic resonance imaging results of optic nerve involvement in eyes primarily enucleated for retinoblastoma.

Authors:  Matthew W Wilson; Carlos Rodriguez-Galindo; Catherine Billups; Barrett G Haik; Fred Laningham; Zoltan Patay
Journal:  Ophthalmology       Date:  2009-07-09       Impact factor: 12.079

View more
  2 in total

1.  Diagnostic performance of MRI of post-laminar optic nerve invasion detection in retinoblastoma: A systematic review and meta-analysis.

Authors:  Se Jin Cho; Jae Hyoung Kim; Sung Hyun Baik; Leonard Sunwoo; Yun Jung Bae; Byung Se Choi
Journal:  Neuroradiology       Date:  2020-08-31       Impact factor: 2.804

2.  The value of MRI in evaluating the efficacy and complications with the treatment of intra-arterial chemotherapy for retinoblastoma.

Authors:  Shuxian Chen; Xunda Ji; Ming Liu; Zhengrong Xia; Hui Zheng; Qiufeng Yin; He Wang; Yuhua Li
Journal:  Oncotarget       Date:  2017-06-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.